• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸球菌在通过小鼠消化道过程中的存活情况。

Survival of lactococci during passage through mouse digestive tract.

作者信息

Kimoto Hiromi, Nomura Masaru, Kobayashi Miho, Mizumachi Koko, Okamoto Takashi

机构信息

Department of Animal Products, National Institute of Livestock and Grassland Science, Tsukuba Norin-danchi, Ibaraki, Japan.

出版信息

Can J Microbiol. 2003 Nov;49(11):707-11. doi: 10.1139/w03-092.

DOI:10.1139/w03-092
PMID:14735220
Abstract

One of the important properties of probiotics is the ability to survive in the intestine. There have been few studies on the probiotic property of lactococci, since they are formally not considered to be natural inhabitants of the intestine. To evaluate lactococci as probiotic bacteria, we investigated their ability to survive during gastric transit by in vitro and in vivo tests. When exposed to an in vitro simulated gastrointestinal environment, such as low pH and bile, only Lactococcus lactis subsp. lactis bv. diacetylactis N7 showed a moderate survival rate among the four strains tested. The tested strains were orally administered to mice, and intestinal passage of the ingested strains was monitored by two methods: antibiotics and PCR. Viable cells of strain N7 were recovered from feces within 24-48 h after administration but not at 72 h. Lactococcus lactis subsp. cremoris ATCC 19257, which had a poor survival rate in vitro test, was also detected at 12 h but not at 24 h. These results indicate that lactococci can reach the mouse intestine alive, but not colonize it. If administered daily, viable strain N7 may exist continuously in the intestine. The effect of strain N7 on intestinal microbial balance and on animal health will be the subject of a further study.

摘要

益生菌的重要特性之一是在肠道内存活的能力。由于乳酸球菌通常不被认为是肠道的天然定植菌,因此关于乳酸球菌益生菌特性的研究较少。为了评估乳酸球菌作为益生菌的潜力,我们通过体外和体内试验研究了它们在胃转运过程中的存活能力。当暴露于体外模拟胃肠道环境(如低pH值和胆汁)时,在所测试的四株菌中,只有乳酸乳球菌乳酸亚种双乙酰乳酸变种N7表现出中等存活率。将测试菌株口服给予小鼠,并通过两种方法监测摄入菌株在肠道中的通过情况:抗生素法和PCR法。在给药后24 - 48小时内从粪便中回收了N7菌株的活细胞,但在72小时时未回收。在体外试验中存活率较低的乳酸乳球菌乳脂亚种ATCC 19257在12小时时也被检测到,但在24小时时未被检测到。这些结果表明,乳酸球菌可以存活到达小鼠肠道,但不能在其中定植。如果每天给药,活的N7菌株可能会在肠道中持续存在。N7菌株对肠道微生物平衡和动物健康的影响将是进一步研究的主题。

相似文献

1
Survival of lactococci during passage through mouse digestive tract.乳酸球菌在通过小鼠消化道过程中的存活情况。
Can J Microbiol. 2003 Nov;49(11):707-11. doi: 10.1139/w03-092.
2
Interference of in vitro and in vivo growth of several intestinal bacteria by Lactococcus strains.乳酸乳球菌菌株对几种肠道细菌体外和体内生长的干扰。
J Microbiol Biotechnol. 2008 Jul;18(7):1286-9.
3
Cholesterol removal from media by lactococci.乳酸乳球菌从培养基中去除胆固醇。
J Dairy Sci. 2002 Dec;85(12):3182-8. doi: 10.3168/jds.S0022-0302(02)74406-8.
4
Monitoring the cell number of Lactococcus lactis subsp. cremoris FC in human feces by real-time PCR with strain-specific primers designed using the RAPD technique.利用随机扩增多态性DNA(RAPD)技术设计的菌株特异性引物,通过实时聚合酶链式反应(PCR)监测人粪便中乳酸乳球菌乳脂亚种FC的细胞数量。
Int J Food Microbiol. 2006 Jul 1;110(1):69-76. doi: 10.1016/j.ijfoodmicro.2006.01.037. Epub 2006 Jun 5.
5
In vitro assessment of the upper gastrointestinal tolerance of potential probiotic dairy propionibacteria.潜在益生菌乳制品丙酸杆菌的上消化道耐受性的体外评估
Int J Food Microbiol. 2004 Mar 15;91(3):253-60. doi: 10.1016/j.ijfoodmicro.2003.07.001.
6
[Characteristics of Lactobacillus strains contained in pharmaceuticals].[药品中所含乳酸杆菌菌株的特性]
Med Dosw Mikrobiol. 2001;53(2):143-9.
7
Probiotic properties of Lactococcus lactis ssp. lactis HV219, isolated from human vaginal secretions.从人类阴道分泌物中分离出的乳酸乳球菌乳酸亚种HV219的益生菌特性。
J Appl Microbiol. 2007 Sep;103(3):629-39. doi: 10.1111/j.1365-2672.2007.03290.x.
8
Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.抗生素/益生菌干预期间摄入的嗜酸乳杆菌LaCH-5和动物双歧杆菌乳亚种Bb-12菌株对四环素的敏感性。
Int J Antimicrob Agents. 2007 Mar;29(3):271-80. doi: 10.1016/j.ijantimicag.2006.09.020. Epub 2007 Jan 5.
9
Increased stress tolerance of Bifidobacterium longum and Lactococcus lactis produced during continuous mixed-strain immobilized-cell fermentation.在连续混合菌株固定化细胞发酵过程中产生的长双歧杆菌和乳酸乳球菌应激耐受性增强。
J Appl Microbiol. 2004;97(3):527-39. doi: 10.1111/j.1365-2672.2004.02326.x.
10
In vitro assessment of the gastrointestinal transit tolerance of taxonomic reference strains from human origin and probiotic product isolates of Bifidobacterium.对源自人类的双歧杆菌分类参考菌株和益生菌产品分离株的胃肠道转运耐受性进行体外评估。
J Dairy Sci. 2007 Aug;90(8):3572-8. doi: 10.3168/jds.2006-548.

引用本文的文献

1
Development of engineered IL-36γ-hypersecreting Lactococcus lactis to improve the intestinal environment.工程化 IL-36γ 高分泌乳球菌的开发,以改善肠道环境。
World J Microbiol Biotechnol. 2024 Oct 24;40(11):363. doi: 10.1007/s11274-024-04157-x.
2
Genetically engineered Lactococcus lactis strain constitutively expresses GABA-producing genes and produces high levels of GABA.经基因工程改造的乳酸乳球菌株持续表达 GABA 生成基因,并产生高水平的 GABA。
Lett Appl Microbiol. 2024 Jun 3;77(6). doi: 10.1093/lambio/ovae051.
3
Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut.
工程化大肠杆菌在肠道原位分泌治疗性纳米抗体。
Cell Host Microbe. 2023 Apr 12;31(4):634-649.e8. doi: 10.1016/j.chom.2023.03.007. Epub 2023 Mar 31.
4
Bee Pollen Diet Alters the Bacterial Flora and Antimicrobial Peptides in the Oral Cavities of Mice.蜂花粉饮食改变小鼠口腔中的细菌菌群和抗菌肽。
Foods. 2021 Jun 4;10(6):1282. doi: 10.3390/foods10061282.
5
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?微生物群作为多发性硬化症的治疗靶点:基因工程益生菌能否治疗该疾病?
Diseases. 2020 Aug 30;8(3):33. doi: 10.3390/diseases8030033.
6
Challenges and Pitfalls in the Engineering of Human Interleukin 22 (hIL-22) Secreting .分泌人白细胞介素22(hIL-22)的工程中的挑战与陷阱
Front Bioeng Biotechnol. 2020 Jun 5;8:543. doi: 10.3389/fbioe.2020.00543. eCollection 2020.
7
A Lactic Acid Bacteria (LAB)-Based Vaccine Candidate for Human Norovirus.基于乳酸菌的人类诺如病毒疫苗候选物。
Viruses. 2019 Mar 2;11(3):213. doi: 10.3390/v11030213.
8
Exploiting Prophage-Mediated Lysis for Biotherapeutic Release by .利用噬菌体介导的裂解作用实现生物治疗药物的释放。
Appl Environ Microbiol. 2019 May 2;85(10). doi: 10.1128/AEM.02335-18. Print 2019 May 15.
9
A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in .一种用于在……中产生和递送白细胞介素-10的新型双歧杆菌表达系统(BEST)
Front Microbiol. 2018 Dec 21;9:3075. doi: 10.3389/fmicb.2018.03075. eCollection 2018.
10
Characterization of a Prophage-Free Derivative Strain of ssp. IL1403 Reveals the Importance of Prophages for Phenotypic Plasticity of the Host.无原噬菌体的ssp. IL1403衍生菌株的特性揭示了原噬菌体对宿主表型可塑性的重要性。
Front Microbiol. 2018 Aug 31;9:2032. doi: 10.3389/fmicb.2018.02032. eCollection 2018.